<p>Figure shows the number of isolates enrolled into the study with nationality of the patients in the left side and number of cases with percentage of overall distribution and geographical origin in the right side.</p
<p>Genotypes of all patients were coded corresponding to nested clades in <a href="http://www.ploson...
The figure shows the distribution of individuals in relation to their clinical classification.</p
<p>(A) Light gray: Western Europe; Dark gray: Eastern Europe. (B) Light gray: Middle East.</p
<p>Note: the numbers to the right and left of the “/”represent the therapy-naïve and the ART individ...
<p>Geographical origin of the patients’ versus number of strain clusters. Figure A shows the geograp...
<p>Details of the 124 samples in this study and the populations that they originated from.</p
<p>Table showing the first 30 entries of likely country of origin for st...
Countries in light grey indicate the origin of participants. Total number of participants: Primary c...
<p>141 samples for the Frequency dataset (A) and 42 samples for the Genotype dataset (B). The popula...
<p>N represents the number of analyzed individuals from each of the sites.</p><p>Geographical origin...
<p>Locations of patients included in the individual patient data meta-analysis. The number indicates...
<p>Geographic origin and sample size (<i>N</i>) for both identification databases, population (Pop) ...
Distribution of the study participants according to their socio-demographic characteristics and cour...
<p>The first column indicates the SMRU clinic site where samples were collected. For each ethnic gro...
<p>The red dots represent diTdP cases and blue dots represent controls (drug-exposed patients and po...
<p>Genotypes of all patients were coded corresponding to nested clades in <a href="http://www.ploson...
The figure shows the distribution of individuals in relation to their clinical classification.</p
<p>(A) Light gray: Western Europe; Dark gray: Eastern Europe. (B) Light gray: Middle East.</p
<p>Note: the numbers to the right and left of the “/”represent the therapy-naïve and the ART individ...
<p>Geographical origin of the patients’ versus number of strain clusters. Figure A shows the geograp...
<p>Details of the 124 samples in this study and the populations that they originated from.</p
<p>Table showing the first 30 entries of likely country of origin for st...
Countries in light grey indicate the origin of participants. Total number of participants: Primary c...
<p>141 samples for the Frequency dataset (A) and 42 samples for the Genotype dataset (B). The popula...
<p>N represents the number of analyzed individuals from each of the sites.</p><p>Geographical origin...
<p>Locations of patients included in the individual patient data meta-analysis. The number indicates...
<p>Geographic origin and sample size (<i>N</i>) for both identification databases, population (Pop) ...
Distribution of the study participants according to their socio-demographic characteristics and cour...
<p>The first column indicates the SMRU clinic site where samples were collected. For each ethnic gro...
<p>The red dots represent diTdP cases and blue dots represent controls (drug-exposed patients and po...
<p>Genotypes of all patients were coded corresponding to nested clades in <a href="http://www.ploson...
The figure shows the distribution of individuals in relation to their clinical classification.</p
<p>(A) Light gray: Western Europe; Dark gray: Eastern Europe. (B) Light gray: Middle East.</p